Market Overview

Zoetis Q2 Earnings Preview

Related ZTS
Paws Up: The First Pets ETF Is Here
The Daily Biotech Pulse: Illumina Snaps Up Pacific Bioscience, Thumbs Down For Alkermes Depressive Disorder Drug
IDEXX Clear Leader in Animal Diagnostics, but Market Growth Could Boost Others (GuruFocus)

On Thursday, Zoetis (NYSE: ZTS) will release its latest earnings report. Check out Benzinga's report to understand the earnings report's implications.

Earnings and Revenue

Zoetis EPS is expected to be around 70 cents, according to sell-side analysts. Sales will likely be near $1.38 billion.

If the company were to match the consensus estimate when it reports Thursday, EPS would be up 32.08 percent. Sales would be up 8.75 percent from the year-ago period. Here's how the company's reported EPS has stacked up against analyst estimates in the past:


Quarter Q1 2018 Q4 2017 Q3 2017 Q2 2017
EPS Estimate 0.69 0.66 0.62 0.53
EPS Actual 0.75 0.69 0.65 0.53

Stock Performance

Over the last 52-week period, shares of Zoetis are up 39.01 percent. Analysts' have adjusted their estimates higher for EPS and revenues over the past 90 days. The average rating by analysts on Zoetis stock is a Neutral. The validity of this rating has maintained conviction over the past 90 days.

Posted-In: Earnings News


Related Articles (ZTS)

View Comments and Join the Discussion!

Jefferies Finds A Reason To Order Papa John's

Earnings Outlook For Becton Dickinson